Becton Dickinson and Co BDX.N reported quarterly adjusted earnings of $3.43 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $2.68. The mean expectation of twelve analysts for the quarter was for earnings of $2.98 per share. Wall Street expected results to range from $2.90 to $3.04 per share.
Revenue rose 9.8% to $5.17 billion from a year ago; analysts expected $5.10 billion.
Becton Dickinson and Co's reported EPS for the quarter was $1.04.
The company reported quarterly net income of $303 million.
Becton Dickinson and Co shares had risen by 8.0% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1.4% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Becton Dickinson and Co is $275.00
This summary was machine generated from LSEG data February 6 at 02:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING |
ESTIMATE |
ACTUAL |
BEAT, MET, MISSED |
Dec. 31 2024 |
2.98 |
3.43 |
Beat |
Sep. 30 2024 |
3.77 |
3.81 |
Beat |
Jun. 30 2024 |
3.31 |
3.50 |
Beat |
Mar. 31 2024 |
2.97 |
3.17 |
Beat |